Group 1 - Hong Kong Stock Exchange condemned Star Health Group Co., Ltd. (formerly known as Aoyuan Health Life Group Co., Ltd.) and several of its directors for failing to fulfill their duties, leading to investor rights violations [1][3] - The case involves Star Health providing RMB 3.3 billion in financial assistance to its then-listed parent company, China Aoyuan, without adhering to the Listing Rules [2] - The violations were attributed to directors not seeking board approval for significant transactions, despite being aware of China Aoyuan's liquidity issues and the financial pressure on Star Health [3] Group 2 - Specific directors, including Guo Zining, Chen Zhibin, and Zheng Wei, were identified as having approved transactions without proper oversight, prioritizing China Aoyuan's interests over those of Star Health [3] - Other directors, although not directly involved in approving the transactions, failed to act in the best interests of Star Health, indicating a lack of adequate internal controls [3] - The Hong Kong Stock Exchange mandated training hours for several directors as part of the disciplinary actions taken against them [1][3]
香港联交所：谴责星悦康旅 对15名董事采取纪律行动